We’re In The News

As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.

Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.

After Health Care Act, Sharp Drop in Spending on Birth Control

The New York Times, July 7, 2015. Out-of-pocket spending on most major birth control methods fell sharply in the months after the Affordable Care Act began requiring insurance plans to cover contraception at no cost to women, a new study has found.

House Overwhelmingly Passes 21st Century Cures Act

Modern Healthcare, July 10, 2015. In a rare act of bipartisanship, House members voted 344-77 on Friday in favor of the 21st Century Cures Act, which supporters say will speed the development and regulatory approval of medical breakthroughs. Critics say that speed would come at the expense of patients’ safety.

Hope For Children’s Rare Drug Approval Process

USA Today (Kaiser Health News), June 7, 2015. A reward program is an extension of the 21st Century Cures bill, which seeks to rewrite the rules for drug development to make innovative treatments available faster.

FDA Reviewing Safety of Essure Birth Control Implant

The Associated Press, June 25, 2015. Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.

House Overwhelmingly Passes Bill to Speed FDA Drug Approvals

The Washington Post, July 10, 2015. The bill’s laundry list of provisions that tweak the process for approving new drugs or devices have raised significant concern from industry watchdogs and physicians who say the legislation is aimed more at helping drug and device companies than patients.